Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Anthropic unveils a $150 million fellowship to place 1,000 AI coaches with nonprofits for a year, funded as the compa...
SpaceX used its soaring stock to fund a $60 billion Cursor acquisition in stock, turning a fresh IPO into a powerful ...
A veteran market analyst argues that military drones, not consumer EVs, may drive the next leap in battery technology...
SpaceX (SPCX) has fallen about 30% from its peak while planning a large debt raise. This guide breaks down what the d...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
Global regulators are tightening the rules around AI financing as investment soars, signaling potential shifts in fun...
Micron unveils a historic plan to expand memory fabrication in the United States, led by CEO Sanjay Mehrotra. The mov...
NVIDIA and TSMC are pursuing opposing routes to AI dominance: an outsized software-driven platform with record margin...
Bill Gates’ foundation says a sudden withdrawal from a major AI summit was a move to keep the focus squarely on the e...
A new market for tariff refunds is taking shape as courts clarify refund rights, drawing funds and individuals into a...
Deadly protests in Pakistan’s Karachi and Gilgit-Baltistan have left at least 22 dead and more than 120 injured as cr...